/
PSIL
$24.50-$0.62 (-2.47%)prev close
Change$-74.52
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$15.63 – $27.02
78% from low
Sector
Asset Management
Exchange
ARCX
ETF
AdvisorShares Psychedelics ETF
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector. It is important to note that this fund maintains a concentrated, non-diversified portfolio.
advisorshares.com/etfs/psil- IPO / List date
- Sep 15, 2021
- HQ
- US
Held by traders on TradeandTell
No one on the platform currently holds PSIL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PSIL as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 7.67% ($1.88/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-22 | $1.6839 | 2025-12-29 |
| 2025-09-22 | $0.0201 | 2025-09-29 |
| 2025-06-23 | $0.0119 | 2025-06-27 |
| 2025-03-21 | $0.1634 | 2025-03-28 |
| 2024-12-23 | $0.0548 | 2024-12-30 |
| 2024-09-23 | $0.1087 | 2024-09-30 |
| 2023-09-25 | $0.0034 | 2023-09-29 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-09-10 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded PSIL yet.
